Standout Papers

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 d... 2018 2026 2020 2023 589
  1. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial (2018)
    Juan P. Frías, Michael A. Nauck et al. The Lancet
  2. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis (2024)
    Rohit Loomba, Mark L. Hartman et al. New England Journal of Medicine
  3. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes (2020)
    Mark L. Hartman, Arun J. Sanyal et al. Diabetes Care
  4. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity (2023)
    Sean Wharton, Thomas Blevins et al. New England Journal of Medicine
  5. Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study (2023)
    Juan P. Frías, Stanley H. Hsia et al. The Lancet

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 111 standout
Sub-graph 1 of 15

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
8 intermediate papers

Works of Deborah A. Robins being referenced

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
2020 Standout
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
2018 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Deborah A. Robins 1633 941 615 26 2.4k
F Alhenc‐Gelas 1916 1161 659 25 4.8k
Christos Tikellis 1160 1072 452 30 3.6k
C. Hübert 1639 996 529 19 4.2k
Salvatore Calanna 2376 1049 1226 27 3.6k
Glenn J. Gormley 1327 531 222 42 4.0k
Katsushi Tsukiyama 1389 746 216 32 2.0k
Barbara G. Kravitz 2378 1902 282 23 3.5k
Ole Schmitz 2209 1510 341 55 3.5k
Mark Heise 2513 1928 317 25 3.5k
Ken L. Chambliss 977 1521 177 49 3.7k

All Works

Loading papers...

Rankless by CCL
2026